SEC 13F Intelligence

Foresite Capital Management IV, LLC / MAZE

Foresite Capital Management IV, LLC’s Maze Therapeutics Inc Position

Does Foresite Capital Management IV, LLC own Maze Therapeutics Inc (MAZE)? Yes — 156.9K shares worth $5M (+1.98% of its 13F portfolio) as of Q1 2026, down from 522.7K shares the prior filed quarter.

Position Value
$5M
Q1 2026
Shares
156.9K
% of Portfolio
+1.98%
Quarters Held
5
currently held

Position History MAZE

Reported value by quarter
Q1 ’25: $23MQ1 ’25Q2 ’25: $26MQ2 ’25Q3 ’25: $14MQ3 ’25Q4 ’25: $22MQ4 ’25Q1 ’26: $5MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026156.9K$5M+1.98%
Q4 2025522.7K$22M+9.43%
Q3 2025522.7K$14M+7.42%
Q2 20252.11M$26M+20.93%
Q1 20252.11M$23M+20.93%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management IV, LLC’s full portfolio or all institutional holders of MAZE.